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Proton magnetic resonance spectroscopy (1H-MRS) was performed in seven healthy volunteers and 17 patients with temporal
lobe epilepsy (TLE) to clarify the correlation of the severity of epilepsy with bilateral temporal changes in N-acetylaspartate
(NAA), choline-containing compounds (Cho) and creatine + phosphocreatine (Cr). Despite unilateral EEG focus, bilateral
temporal reduction in NAA/(Cho + Cr) was revealed in patients with intractable seizures. The potential for seizure generation
correlated with the NAA/(Cho + Cr) reduction not only on the ipsilateral side but also on the contralateral side. Proton MRS
proved to be a useful measurement for obtaining important information about the neuronal changes as well as the lateralization
of the epileptogenic focus in TLE patients.
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INTRODUCTION
Pathological subgroups of temporal lobe
epilepsy (TLE) are of two general types: most pa-
tients have mesial temporal sclerosis (neuronal cell
loss and reactive gliosis) and a minority has a focal
epileptogenic mass lesion (e.g. tumor or atriovenous
malformation (AVM))1. Surgical treatment for med-
ically intractable TLE is an effective procedure in
selected patients in whom the epileptogenic focus in
localized in a unilateral mesial temporal lobe (MTL)2.
Accurate localization of the epileptogenic focus has
largely and traditionally been dependent on a scalp-
sphenoidal electroencephalogram (EEG). Recently,
magnetic resonance imaging (MRI), positron emis-
sion tomography (PET) and single-photon emission
computed tomography (SPECT) have provided impor-
tant independent information about the epileptogenic
focus3–6. However, subdural EEG electrode implan-
tation is still required for 30–50% of patients when
imaging and scalp EEG disagree or are inconclusive7.
A more sensitive and noninvasive neurologic measure-
ment modality is needed, which interictally lateralizes
the epileptogenic focus, and gives us useful informa-
tion about the pathological changes of TLE.
Proton magnetic resonance spectroscopy (1H-MRS)
is a noninvasive functional neurologic measurement
modality. Proton MRS spectra of the brain include
major contributions from N-acetylaspartate (NAA),
choline-containing compounds (Cho) and creatine +
phosphocreatine (Cr). There have been several stud-
ies, as shown in Table 1, that observed a reduction in
the NAA signal or its ratio to other metabolism sig-
nals in the ipsilateral temporal lobe to the epilepto-
genic focus in TLE patients5, 8–14. In some of these
studies, MRS lateralization proved superior in agree-
ment rate with EEG lateralization to inspective or vol-
umetric MRI5, 8, 9, 11, 12. Further, there have been MRS
studies demonstrating the bilateral temporal reduction
of NAA/(Cho + Cr) in TLE patients5, 8, 9, 11, 13. NAA
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is located primarily within neurons15. Therefore, a re-
duction in the NAA signal, or in its ratio to other
metabolism signals, might be interpreted in terms of
neuronal loss or damage5, 11. However, the pathophys-
iological meaning of this NAA reduction either on the
ipsilateral side to the epileptogenic focus or on the
contralateral side has been not fully understood. To
clarify this, the relationship between the severity of
TLE and bilateral 1H-MRS signals must be thoroughly
investigated. However, as shown in Table 1, there have
been few studies to focus on this, since most 1H-MRS
studies were carried out as presurgical assessments
and investigated only the patients with intractable TLE
who failed to respond to any medical treatment.
In the present study, we aimed to evaluate the bi-
lateral change in the 1H-MRS signals in TLE patients
with a relatively wide range of severity from almost
seizure-free to intractable, and to clarify the correla-
tion of seizure frequency with the bilateral changes as
revealed by 1H-MRS.
MATERIALS AND METHODS
Subjects
This study was approved by the Ethics and Radiation
Safety Committee of the National Institute of Radio-
logical Sciences, Chiba, Japan. We studied 17 patients,
5 males and 12 females, 31.2 ± 7.9 y (mean ± SD),
who were diagnosed as the amygdala-hippocampus
type of TLE based on clinical symptoms and EEG
findings16. The clinical backgrounds of the patients
are summarized in Table 2. They were asked to par-
ticipate in this study after written informed consent
was obtained. They showed autonomic seizures, epi-
gastric aura, nausea, vomiting or headache, and had
no organic abnormal lesions (dysembryoplastic neu-
roepithelial tumor, cavernous angina, etc.) in the lat-
eral cortex. All of the patients showed unilateral tem-
poral spikes or sharp waves in their repetitive (three or
more) EEG records. Laterality of the epileptogenic fo-
cus was determined by repetitive scalp EEG in 15 pa-
tients, and by stereotactic implanted depth electrode
EEGs in two patients because scalp EEGs did not pro-
vide clear localization or lateralization on seizure on-
set. Based on seizure frequency during the one-year
period before examination, we quantified the average
seizure frequency per month for each patient. Further-
more, we divided the patients into two groups, group 1
(n = 7) and group 2 (n = 10). Group 1 patients
had a history of repetitive seizures but their present
seizure frequencies were controlled with anticonvul-
sants at less than once a month. Group 2 patients were
not controlled with anticonvulsants and experienced a
seizure at least once a month. Seven healthy volun-
teers aged 27.0 ± 5.4 y (mean ± SD), five males and
two females, were also studied as controls.
Magnetic resonance spectroscopy
The MR system used in this study was a Gyroscan
ACS2 operated at 1.5 T (Philips Medical Systems,
Ltd.). Proton MRS was performed with a birdcage-
type coil. The volumes of interest (VOIs) were set
at the bilateral MTLs guided by proton scout images.
The VOIs were set in a size of 6× 3× 3 cm to include
all parts of the hippocampus; the head, body, tail, gray
and white matter, and amygdala. The use of a large
voxel size may dilute the measured spectroscopy but
it enables us to obtain stable and reproductive data.
Volume selection was done by spin echo sequence for
each side. Repetition time (TR) was 1500 ms, and echo
time (TE) was 136 ms. There were 1024 data points,
and the bandwidth was 2000 Hz. Scan averages were
256 times and scan time was 6.4 min for each side.
To evaluate the structural brain changes, approxi-
mately 92 coronal MR images, covering the entire
brain, were taken for each subject. An inversion re-
covery pulse sequence (TR, 2500 ms; TE, 20 ms;
inversion time, 300 ms) was used. Matrix size was
205×256, and FOV was 230 mm. Slice thickness was
2 mm without slice gaps. Total scan time was 21 min
and 25 s. The coronal slice images were parallel to the
baseline of the fourth ventricle. Atrophy of the MTL
was judged by two experienced specialists, a radiolo-
gist and a neuropsychiatrist, while blinded to the EEG
lateralization. MTL atrophy was detected in five pa-
tients (Table 2). Their lateralities were consistent with
the EEG lateralities.
Data processing and analysis
After a Fourier transformation, the spectra were zero-
and first-order phase-corrected. To measure the area
under each peak, a semi-automatic line-fitting rou-
tine assuming a purely Lorentzian lineshape was used.
NAA intensities were evaluated as a relative ratio to
the total ratio of Cho + Cr. The large VOI used in this
study to cover all parts of the hippocampus may be
thought to cause partial volume effects. However, the
contaminated signal from extra brain tissue was very
low. Thus, the use of the relative value of the ratio of
NAA to Cho + Cr could minimize any partial volume
effect of extra brain tissue.
The paired t-test was used for comparisons of the
ipsilateral and contralateral MTLs to the EEG focus.
One-way analysis of variance (ANOVA) and Fisher’s
PLSD for post-hoc test were used to analyse differ-
ences among the three groups (group 1, 2 and control
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Table 1: Review of proton magnetic spectroscopy.
Agreement rate with EEG Bilateral change
Number lateralization 1H-MRS MRI in 1H-MRS
Author Year Subject (Patient/Control) Variables % % %
Hugg, J. W.12 1993 intractable TLE 8/8 N 100 > 88 —
Gadian, D. G.10 1994 intractable TLE 82/15 N/Ch+Cr, N, Cr, Ch — > — —
Cendes, F.8 1993 intractable TLE 10/5 Cr/N 80 > 80 20
N 100 — —
Connelly, A.9 1994 intractable TLE 25/13 N/Ch+Cr 88 > 76 40
N 22 — —
Hetherington, H.11 1995 intractable TLE 10/10 Cr/N 100 > 70 40
Ch/N 80 — —
Knowlton, R. C.13 1997 intractable TLE 23/11-19 N.Ch+Cr 61 < 65 33
N 57 — —
Cendes, F.5 1997 intractable TLE 100/20 N/Cr 86 > 83 54
Mendes, R. J.14 1998 intractable and 10/10 N/Cr, N/Ch — — —
seizure-free TLE 12/10 N/Cr (NS), N/Ch — — —
TLE = temporal lobe epilepsy; EEG = electroencephalogram; 1H-MRS = proton magnetic resonance spectroscopy; MRI = magnetic
resonance imaging; PET = positron emission tomography; N = N-acetylaspartate; Ch = choline; Cr = creatine
Table 2: Patient demographic information.
Onset Epilepsy Seizure Seizure frequency
Subject Sex Age age (y) duration (y) EEG Focus type per month MRI
1 F 47 20 27 LtAT.MT SPS + CPS + SGS 3.6 Atrophy of Lt-MTL
2 F 40 15 25 LtAT.MT CPS + SGS 2.6 —
3 F 37 18 19 RtMT SPS + CPS + SGS 33.3 —
4 F 37 9 28 LtAT.MT SPS + CPS + SGS 3 —
5 F 34 30 4 LtAT SPS <1 —
6 F 34 10 24 LtAT CPS + SGS 8.5 —
7 F 30 10 20 LtAT.MT SPS + CPS <1 —
8 F 23 9 14 LtMT SPS + CPS + SGS 2.8 Antrophy of Lt-MTL
9 F 20 15 5 LtAT.MT SPS + CPS <1 Antrophy of Lt-MTL
10 F 20 15 5 RtMT, LtFp and MT SPS + CPS 18.3 —
11 F 27 2 25 LtFP, AT CPS <1 Antrophy of Lt-MTL
12 F 22 20 2 LtAT.MT SPS + CPS <1 —
13 M 39 3 36 RtAT.MT CPS + SGS 8.8 —
14 M 36 6 30 RtMT CPS 9.5 Antrophy of Rt-MTL
15 M 33 22 11 RtAT CPS + SGS 2.1 —
16 M 30 26 4 RtMT CPS <1 —
17 M 22 14 8 LtAT.MT SPS + CPS <1 —
EEG = electroencephalogram; MRI = magnetic resonance imaging; Lt = left; Rt = right; Fp = frontpolar; AT = anterior temporal; MT =
mid-temporal; MTL = mesial temporal lobe; SPS = simple partial seizure; CPS = complex partial seizure; SGS = secondarily generalized
seizure.
subjects). Logarithmic transformation was used to nor-
malize the data of seizure frequency. Pearson product–
moment correlation analysis was used to evaluate the
correlation between the 1H-MRS data and the seizure
frequency.
RESULTS
NAA/(Cho + Cr) ratios in the ipsilateral MTLs to the
EEG focus were significantly lower than those in the
contralateral MTLs (P < 0.01; paired t-test). Proton
MRS lateralization based on a reduced NAA/(Cho +
Cr) ratio agreed with the clinical-EEG lateralization in
15 of 17 patients.
NAA/(Cho + Cr) in the bilateral MTLs of the
groups with different seizure frequencies and the con-
trols are shown in Fig. 1. When the patients were
divided into two groups, group 2 patients showed a
significant difference between the ipsilateral and con-
tralateral MTLs (P < 0.01; paired t-test) but group 1
patients showed no significant difference.
There were significant between-groups differences
(group 1,2 and controls) in NAA/(Cho + Cr) not only
in the ipsilateral MTLs (F = 20.6, df = [2, 28],
P = 0.001; ANOVA) but also in the contralateral
MTLs (F = 7.3, df = [2, 28], P = 0.0028; ANOVA).
Group 1 patients showed no significant differences
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compared with controls in either ipsilateral or con-
tralateral MTLs by post-hoc test, whereas group 2
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Fig. 1: NAA/(Cho + Cr) ratios in the bilateral mesial tem-
poral lobes (MTLs) of the groups with different seizure fre-
quencies and the controls. Group 1 (n = 7): patients were
controlled with anticonvulsants at less than once a month.
Group 2 (n = 10): patients were not controlled with anticon-
vulsants and had a seizure at least once a month. * Signifi-
cantly different from contralateral MTLs (P < 0.01: paired t-
test). + Significantly different from controls (ipsilateral MTLs,
P < 0.01; contralateral MTL, P < 0.01; Fisher’s PLSD for the
post-hoc test).
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Fig. 2: Correlation between seizure frequency and NAA/(Cho
+ Cr) ratio. Logarithmic transformation was used to normal-
ize seizure frequencies. The lines represent expected values
in contralateral (dotted line) and ipsilateral (solid line) MTLs
obtained by linear regression.
patients exhibited a significant decrease compared to
controls in both ipsilateral and contralateral MTLs
(P < 0.01; Fisher’s PLSD).
Figure 2 shows the correlation between the
NAA/(Cho + Cr) ratio and seizure frequency. The
NAA/(Cho + Cr) reduction correlated with the
seizure frequency not only in the ipsilateral MTLs
(r = −0.83, P < 0.01) but also in the contralateral
MTLs (r = −0.67, P < 0.01).
DISCUSSION
Proton MRS lateralization based on reduced
NAA/(Cho + Cr) agreed with the clinical EEG later-
alization in 15 of 17 patients. The NAA/(Cho + Cr)
ratios in the ipsilateral MTLs were significantly lower
than those in the contralateral MTLs. These results
were consistent with several studies that reported re-
duction in NAA signals or NAA/(Cho + Cr) ratios in
ipsilateral MTLs of TLE patients5, 8–14.
Mesial temporal sclerosis characterized by loss of
neurons, atrophy and gliosis is found in the resected
hippocampal formation of up to 70% of patients re-
ceiving temporal lobectomy for intractable TLE2, 17.
NAA is believed to be located primarily within neu-
rons15, and the loss of NAA signals is consistent with
neuronal loss or damage5, 11. While the basis for the
increase in the Cho and Cr signals remains unclear,
one possible explanation is provided by the study
of neuronal cells, which showed that the concentra-
tions of Cho and Cr are much higher in astrocyte and
oligodendrocyte preparations than in cerebellar gran-
ule neurons18. It may be that the changes in Cho and
Cr reflect reactive astrocytosis. Thus, the decrease in
NAA/(Cho + Cr) ratios in ipsilateral MTLs may re-
flect the neuronal loss and reactive gliosis as observed
in mesial temporal sclerosis in TLE.
It has been shown that MR imaging could detect the
atrophic changes of the MTL in some patients with
TLE. In this study, atrophy of the MTL was confirmed
in only five patients. Two patients were seizure-free,
and three patients were intractable. Their lateralities
were consistent with EEG lateralities. These results
are in line with the studies demonstrating the NAA
reduction in patients without hippocampal atrophy on
MRI5, 13, and suggest that the NAA/(Cho + Cr) value
was not affected by the partial volume effect of the
volume of interest, and that 1H-MRS may be able
to detect regional neuronal changes before structural
changes are seen by conventional MRI. However, in
the present study, we determined the atrophy of MTL
only by inspective judgement. Further studies should
be performed using quantitative analyses of MTL.
Our finding of NAA reduction in patients without
hippocampal atrophy also suggests that NAA/(Cho +
Cr) reduction may not simply reflect neuronal loss.
One possible explanation is that astrocyte gliosis re-
places some of the volume of neurons when they
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are lost or damaged. Another possibility has been
suggested, that some part of NAA reduction is due
to disturbed mitochondrial metabolism caused by re-
peated seizure activity19. The cellular mechanisms of
NAA/(Cho + Cr) reduction need to be clarified by
correlative neuropathologic studies.
Most MRS studies examined intractable TLE pa-
tients for presurgical evaluation5, 10–13. Consequently,
the correlation of 1H-MRS signal with the severity of
epilepsy has remained unclear. Recently, a group of
TLE patients seizure-free for a considerable time was
investigated using single-volume 1H-MRS, and no sig-
nificant reduction of the NAA/Cr ratio in the ipsilat-
eral MTL to the EEG focus was observed19. However,
two patients who were seizure-free but had a history
of poor seizure control showed a lower NAA/Cr ratio,
suggesting that NAA/Cr ratios were associated with
poor seizure control at some time in their lives. In the
present study, we found that seizure frequency was
negatively correlated with the NAA/(Cho + Cr) ratio
not only in the ipsilateral MTL but also in the con-
tralateral MTL, although the contralateral effects were
less severe than the ipsilateral ones. It is well known
that seizures appear to begin bilaterally in many pa-
tients with intractable TLE2. In the present series of
patients, lateralization of the epileptogenic focus was
determined mainly by repetitive interictal scalp EEGs
only. Thus, some patients with bilateral epileptogenic
foci might be included in the present study. However,
bilateral temporal changes in TLE patients with unilat-
eral EEG abnormality have been reported in MRS9, 14,
MRI20 and neuropathologic studies21. These observa-
tions are in agreement with the present findings. There
have been few investigations regarding the correlation
between bilaterally abnormal MRS and seizure fre-
quency. The present study indicates that the bilateral
NAA/(Cho + Cr) reduction in TLE patients is closely
related to the potential for seizure generation.
The presence of bilateral spectral abnormalities
probably reflects the underlying pathology. How-
ever, it has not been confirmed that the contralateral
NAA/(Cho + Cr) reduction simply reflects mesial
temporal sclerosis. It has been reported that bilater-
ally abnormal MRS does not preclude a good surgi-
cal outcome9, 13, and also that contralateral MRS ab-
normality was normalized after surgical elimination
of seizures in two TLE patients22. These results sug-
gest that the contralateral MRS abnormality includes
some reversible metabolic changes secondary to the
repetitive occurrence of seizures19. However, to clarify
these findings, further studies of the dynamic changes
in MRS spectra in relation to the repetitive occurrence
of seizures are required.
CONCLUSION
Proton MRS revealed the bilateral temporal reduction
in NAA/(Cho + Cr) in TLE patients with unilateral
EEG focus. The potential for seizure generation was
correlated with the NAA/(Cho + Cr) reduction not
only in the ipsilateral MTL but also in the contralat-
eral MTL. Proton MRS proved to be a sensitive and
useful measurement procedure, and to provide impor-
tant information concerning the neuronal changes as
well as lateralization of the epileptogenic focus in TLE
patients.
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